In contrast, methylation seems to have a potential impact on the biology of colorectal tumours by negatively modulating the expression of PKCΒ. Given the role of PKCΒ as the potential target for anti-cancer therapy, further investigation of PKCΒ methylation and expression in CRC could be of great importance for the development of future therapeutic strategies. Here, PRRT2 is linked to colorectal carcinoma.